Editor
Surescripts named an outsider, Frank Harvey, as its CEO, the e-prescription company said Monday.
Harvey, who most recently led private-equity investments for healthcare technology companies at ATLS Investments, will take the helm June 27. He succeeds Tom Skelton, who in November announced plans to retire.
Before ATLS Investments, Harvey served as CEO of Mirixa, a technology company focused on medication therapy management that was acquired by…
